학술논문
An observational study of bevacizumab combined with FOLFIRI as the first-line treatment in metastatic colorectal cancer
Document Type
Article
Author
Source
In Genomic Medicine, Biomarkers, and Health Sciences December 2012 4(4):122-127
Subject
Language
ISSN
2211-4254